Delivering Small Molecules to the Clinic Faster – One Stop CMC

Welcome to J-STAR Research, Inc., a subsidiary of Porton Pharma Solutions Ltd.

Our mission is to help pharmaceutical small molecule R&D programs succeed in all phases of development.

Integrated DS-DP Services in USA

Two scientists in white lab coats and gloves working in a laboratory, with one examining a test tube and the other focused on an experiment.

Process R&D/Drug Substance

Four scientists in white lab coats and masks stand in a laboratory setting, with one pointing to equipment on a table.

Drug Product

Two scientists in lab coats work in a laboratory; one examines a sample under a microscope, while the other uses a computer in the background.

Crystallization R&D

A person in a lab coat and gloves carefully pours liquid from a pipette into a flask in a laboratory setting.

Analytical R&D and Quality Control

A scientist wearing protective eyewear and a lab coat operates laboratory equipment, adjusting a component with blue gloves.

High Potent Compound & Controlled Substances

Exceptional Customer Service

Led by a strong management team, J-STAR Research provides the highest level of scientific expertise, customer service and personal attention to every project.

Innovative Problem-Solving

Creative J-STAR scientists are assigned to projects based on their technical acumen and problem-solving ability.

State of the Art Facilities

Two NJ-based R&D centers totaling 129,000 SF.

Latest Equipment

J-STAR has an industry-leading suite of analytical, automation and PAT instrumentation.

News

More >

Two people shaking hands with the text "Porton Aojin" and a handshake icon in between, symbolizing a strategic collaboration.

Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S.

December 11, 2024

The building exterior showcases a landscaped garden, reflecting Porton's commitment to sustainable development, with a prominent sign displaying "PORTON" in large letters.

Porton Recognized as an Exemplary Case for Sustainable Development Among Chinese Listed Companies in 2024

December 6, 2024

A laptop and smartphone display the redesigned website of Porton Pharma Solutions, featuring scientific visuals, information about CDMO services, and a global presence map.

Porton Pharma Solutions is thrilled to announce the launch of its newly redesigned official website

December 6, 2024